Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Therapeutic Advances in Drug Safety | journal | 0.837 Q2 | 46 | 35 | 123 | 1607 | 454 | 102 | 2.87 | 45.91 | 44.02 | |
52 | Antiviral Therapy | journal | 0.835 Q2 | 93 | 46 | 182 | 879 | 437 | 174 | 1.65 | 19.11 | 52.26 | |
53 | AIDS Research and Therapy | journal | 0.827 Q2 | 49 | 99 | 134 | 3589 | 377 | 134 | 2.84 | 36.25 | 41.32 | |
54 | Therapeutic Advances in Cardiovascular Disease | journal | 0.816 Q2 | 41 | 10 | 75 | 428 | 201 | 66 | 3.11 | 42.80 | 17.14 | |
55 | Antibiotics | journal | 0.785 Q2 | 77 | 1553 | 1305 | 93008 | 6858 | 1277 | 5.08 | 59.89 | 47.93 | |
56 | Pharmaceutical Statistics | journal | 0.775 Q2 | 46 | 94 | 198 | 2696 | 247 | 184 | 1.01 | 28.68 | 27.70 | |
57 | Inflammopharmacology | journal | 0.772 Q2 | 68 | 138 | 366 | 8645 | 1721 | 360 | 4.66 | 62.64 | 44.32 | |
58 | Chemotherapy | journal | 0.742 Q2 | 61 | 39 | 98 | 1209 | 286 | 95 | 3.06 | 31.00 | 38.20 | |
59 | Expert Opinion on Pharmacotherapy | journal | 0.735 Q2 | 93 | 236 | 670 | 18660 | 2242 | 576 | 3.44 | 79.07 | 38.19 | |
60 | European Journal of Clinical Pharmacology | journal | 0.732 Q2 | 123 | 211 | 607 | 6867 | 1647 | 511 | 2.68 | 32.55 | 44.36 | |
61 | Cardiovascular Therapeutics | journal | 0.725 Q2 | 54 | 37 | 150 | 1540 | 510 | 149 | 3.36 | 41.62 | 44.91 | |
62 | Clinical Drug Investigation | journal | 0.718 Q2 | 67 | 108 | 364 | 3657 | 1097 | 334 | 3.05 | 33.86 | 39.69 | |
63 | Paediatric Drugs | journal | 0.709 Q2 | 70 | 49 | 153 | 3421 | 591 | 147 | 4.17 | 69.82 | 48.57 | |
64 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.685 Q2 | 57 | 73 | 187 | 4001 | 505 | 179 | 2.51 | 54.81 | 32.88 | |
65 | European Review for Medical and Pharmacological Sciences | journal | 0.658 Q2 | 88 | 1145 | 3808 | 37743 | 14029 | 3687 | 3.65 | 32.96 | 40.91 | |
66 | Photodiagnosis and Photodynamic Therapy | journal | 0.643 Q2 | 67 | 466 | 981 | 18020 | 3598 | 949 | 3.49 | 38.67 | 44.74 | |
67 | Pharmaceutical Medicine | journal | 0.617 Q2 | 25 | 37 | 108 | 1011 | 236 | 98 | 2.70 | 27.32 | 49.24 | |
68 | HIV Research and Clinical Practice | journal | 0.612 Q2 | 54 | 21 | 66 | 917 | 119 | 65 | 1.54 | 43.67 | 45.54 | |
69 | Journal of Infection and Chemotherapy | journal | 0.588 Q2 | 72 | 314 | 676 | 7988 | 1584 | 670 | 2.14 | 25.44 | 24.79 | |
70 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.552 Q2 | 61 | 118 | 225 | 5434 | 530 | 213 | 2.12 | 46.05 | 46.46 | |
71 | International Journal of STD and AIDS | journal | 0.537 Q2 | 78 | 185 | 633 | 5635 | 844 | 602 | 1.16 | 30.46 | 50.80 | |
72 | Fundamental and Clinical Pharmacology | journal | 0.534 Q2 | 85 | 107 | 232 | 5893 | 618 | 207 | 2.74 | 55.07 | 49.13 | |
73 | Drugs - Real World Outcomes | journal | 0.532 Q2 | 21 | 51 | 83 | 1902 | 190 | 80 | 2.05 | 37.29 | 38.01 | |
74 | European Journal of Drug Metabolism and Pharmacokinetics | journal | 0.530 Q2 | 47 | 67 | 221 | 2465 | 575 | 214 | 2.60 | 36.79 | 38.42 | |
75 | Cardiology | journal | 0.524 Q2 | 72 | 105 | 344 | 2916 | 511 | 271 | 1.31 | 27.77 | 28.19 | |
76 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.517 Q2 | 81 | 232 | 499 | 7126 | 1162 | 465 | 2.35 | 30.72 | 47.35 | |
77 | PharmacoEconomics - Open | journal | 0.506 Q3 | 20 | 68 | 171 | 2655 | 323 | 155 | 1.74 | 39.04 | 36.78 | |
78 | International Journal of Clinical Pharmacy | journal | 0.501 Q3 | 71 | 196 | 540 | 6367 | 1353 | 498 | 2.29 | 32.48 | 51.34 | |
79 | BMC pharmacology & toxicology | journal | 0.497 Q3 | 43 | 72 | 261 | 2911 | 762 | 261 | 2.52 | 40.43 | 42.04 | |
80 | AIDS Reviews | journal | 0.489 Q3 | 62 | 20 | 102 | 725 | 159 | 84 | 1.71 | 36.25 | 33.65 | |
81 | European Journal of Contraception and Reproductive Health Care | journal | 0.457 Q3 | 53 | 75 | 234 | 2424 | 402 | 204 | 1.73 | 32.32 | 60.22 | |
82 | Human Psychopharmacology | journal | 0.448 Q3 | 86 | 40 | 96 | 1995 | 202 | 96 | 2.44 | 49.88 | 39.54 | |
83 | EJNMMI Radiopharmacy and Chemistry | journal | 0.447 Q3 | 28 | 35 | 76 | 1244 | 370 | 73 | 5.26 | 35.54 | 31.17 | |
84 | Therapies | journal | 0.442 Q3 | 41 | 110 | 250 | 2930 | 479 | 183 | 2.47 | 26.64 | 54.32 | |
85 | Journal of Chemotherapy | journal | 0.429 Q3 | 56 | 64 | 182 | 2466 | 382 | 171 | 2.20 | 38.53 | 49.64 | |
86 | PharmaNutrition | journal | 0.402 Q3 | 30 | 29 | 107 | 1681 | 305 | 105 | 3.04 | 57.97 | 48.65 | |
87 | Drugs of Today | journal | 0.396 Q3 | 57 | 52 | 169 | 2496 | 390 | 169 | 2.44 | 48.00 | 32.77 | |
88 | Journal of Oncology Pharmacy Practice | journal | 0.374 Q3 | 44 | 312 | 724 | 7213 | 1104 | 664 | 1.54 | 23.12 | 51.00 | |
89 | Drug Target Insights | journal | 0.365 Q3 | 16 | 5 | 12 | 193 | 30 | 11 | 2.60 | 38.60 | 40.00 | |
90 | Frontiers in Clinical Drug Research - Anti Infectives | book series | 0.359 Q3 | 2 | 13 | 14 | 1862 | 8 | 2 | 0.57 | 143.23 | 63.89 | |
91 | International Journal of Clinical Pharmacology and Therapeutics | journal | 0.356 Q3 | 73 | 106 | 269 | 2566 | 350 | 252 | 1.02 | 24.21 | 41.56 | |
92 | Biopharmaceutics and Drug Disposition | journal | 0.335 Q3 | 65 | 38 | 110 | 1664 | 198 | 109 | 1.77 | 43.79 | 44.90 | |
93 | Clinica e Investigacion en Arteriosclerosis | journal | 0.325 Q3 | 21 | 63 | 122 | 2306 | 213 | 120 | 1.94 | 36.60 | 48.51 | |
94 | Psychiatry and Clinical Psychopharmacology | journal | 0.313 Q3 | 24 | 59 | 283 | 2281 | 302 | 277 | 1.02 | 38.66 | 48.22 | |
95 | Drug Metabolism and Personalized Therapy | journal | 0.311 Q3 | 38 | 57 | 97 | 2424 | 174 | 93 | 1.93 | 42.53 | 35.21 | |
96 | Medicine in Drug Discovery | journal | 0.306 Q3 | 16 | 33 | 4 | 2439 | 30 | 3 | 7.50 | 73.91 | 38.26 | |
97 | Synergy | journal | 0.275 Q3 | 15 | 0 | 28 | 0 | 69 | 27 | 1.17 | 0.00 | 0.00 | |
98 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.254 Q3 | 46 | 49 | 73 | 2216 | 374 | 72 | 4.10 | 45.22 | 38.33 | |
99 | Frontiers in Clinical Drug Research - Alzheimer Disorders | book series | 0.248 Q3 | 3 | 0 | 7 | 0 | 4 | 1 | 0.57 | 0.00 | 0.00 | |
100 | Expert Opinion on Orphan Drugs | journal | 0.222 Q3 | 27 | 28 | 180 | 1958 | 164 | 170 | 1.02 | 69.93 | 38.89 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®